Table 4.
No. of studies reporting outcomes (n = 39) | Range of rates reported (%)* | |
---|---|---|
Adverse events | ||
Device removal | 27 | 0·5–8·3 |
Device erosion | 8 | 0·1–1·2 |
Need for dilatation | 22 | 2–67 |
Readmission to hospital within 30 days | 13 | 1·3–5·4 |
Mortality | 3 | 0 |
Clinical | ||
DeMeester score | 7 | – |
Manometry | 4 | – |
Oesophageal pH testing | 10 | – |
Oesophagogastroduodenoscopy | 13 | – |
Barium swallow | 7 | – |
Proton pump inhibitor use | 25 | – |
Process | ||
Duration of operation (min) | 16 | 23–184† |
Duration of hospital stay (days) | 13 | 0–3† |
Patient‐reported outcomes | ||
GERD‐HRQL score | 31 | – |
Other validated patient‐reported outcomes | 7 | – |
Non‐validated patient‐reported outcome | 5 | – |
Economic | ||
Costs associated with device | 1 | – |
Unless indicated otherwise;
values are median (range). GERD‐HRQL, gastro‐oesophageal reflux disease – health‐related quality of life.